These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 15806488

  • 1. Cyclophosphamide or chlorambucil therapy is indicated in idiopathic membranous nephropathy with strong risk factors for progression.
    Hebert LA, Rovin BH, Agarwal AK, Spetie DN.
    Am J Kidney Dis; 2005 Apr; 45(4):788-9; author replyy 789-90. PubMed ID: 15806488
    [No Abstract] [Full Text] [Related]

  • 2. Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis.
    Ren S, Wang Y, Xian L, Toyama T, Jardine M, Li G, Perkovic V, Hong D.
    PLoS One; 2017 Apr; 12(9):e0184398. PubMed ID: 28898290
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Oral cyclophosphamide versus chlorambucil in the treatment of patients with membranous nephropathy and renal insufficiency.
    Branten AJ, Reichert LJ, Koene RA, Wetzels JF.
    QJM; 1998 May; 91(5):359-66. PubMed ID: 9709470
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Preserving renal function in patients with membranous nephropathy: daily oral chlorambucil compared with intermittent monthly pulses of cyclophosphamide.
    Reichert LJ, Huysmans FT, Assmann K, Koene RA, Wetzels JF.
    Ann Intern Med; 1994 Sep 01; 121(5):328-33. PubMed ID: 8042821
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of immunosuppressive treatment in patients with membranous nephropathy and renal insufficiency.
    Wetzels JF, Reichert LJ.
    Kidney Int Suppl; 1997 Oct 01; 61():S63-6. PubMed ID: 9328969
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Corticosteroids, cyclophosphamide, and chlorambucil therapy of membranous nephropathy.
    Passerini P, Ponticelli C.
    Semin Nephrol; 2003 Jul 01; 23(4):355-61. PubMed ID: 12923723
    [Abstract] [Full Text] [Related]

  • 10. Therapy of membranous nephropathy with severe azotemia.
    Prabhakar S, Kahn T.
    Clin Nephrol; 1996 Jun 01; 45(6):419. PubMed ID: 8793240
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Introduction of a cyclophosphamide-based treatment strategy and the risk of ESRD in patients with idiopathic membranous nephropathy: a nationwide survey in the Netherlands.
    Hofstra JM, Wetzels JF.
    Nephrol Dial Transplant; 2008 Nov 01; 23(11):3534-8. PubMed ID: 18559961
    [Abstract] [Full Text] [Related]

  • 16. [Membranous nephropathy].
    Passos EM, Legallicier B, Godin M.
    Rev Prat; 2003 Nov 30; 53(18):2033-8. PubMed ID: 15008218
    [Abstract] [Full Text] [Related]

  • 17. ACTH and azathioprine: antiproteinuric and lipid-lowering effect in the course of idiopathic membranous glomerulonephritis.
    Gigante A, Rosato E, Liberatori M, Gasperini ML, Giannakakis K, Barbano B, Cianci R, Salsano F, Amoroso A.
    J Biol Regul Homeost Agents; 2012 Nov 30; 26(1):135-8. PubMed ID: 22475105
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Application of artificial neural networks in estimating predictive factors and therapeutic efficacy in idiopathic membranous nephropathy.
    Naumovic R, Furuncic D, Jovanovic D, Stosovic M, Basta-Jovanovic G, Lezaic V.
    Biomed Pharmacother; 2010 Nov 30; 64(9):633-8. PubMed ID: 20888177
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.